Neonatology pp 608-610 | Cite as

Bilirubin Metabolism, Unconjugated Hyperbilirubinemia, Physiological Neonatal Jaundice

  • Giovanna Bertini
  • Carlo Dani


Jaundice is the most frequent condition identified in a newborn. Recent data show that about 25% of neonates have visible jaundice during their hospitalization, and 5.1% have a serum total bilirubin (STB) concentration >12.9 mg/dL (220.59 µmol/L) [1].


Biliary Atresia Serum Total Bilirubin Hereditary Spherocytosis Neonatal Jaundice Neonatal Hyperbilirubinemia 


  1. 1.
    Bertini G, Dani C, Tronchin M, Rubaltelli FF (2001) Is breastfeeding really favoring early neonatal jaundice? Pediatrics 107: E41PubMedCrossRefGoogle Scholar
  2. 2.
    Stevenson DK, Bartoletti AL, Ostrander CR, Johnson JD (1980) Pulmonary excretion of carbon monoxide in the human infants as an index of bilirubin production. IV: Effects of breast-feeding and caloric intake in the first postnatal week. Pediatrics 65: 1170–1172Google Scholar
  3. 3.
    Rubaltelli FF (1993) Bilirubin metabolism in the newborn. Biol Neonate 63: 133–138PubMedCrossRefGoogle Scholar
  4. 4.
    Jori G, Reddi E, Rubaltelli FF (1988) Structural and functional differences between fetal and adult serum albumin. Int J Pept Protein Res 31: 17–21PubMedCrossRefGoogle Scholar
  5. 5.
    Maisels MJ, Newman TB (1995) Kernicterus in otherwise healthy, breastfed term newborns. Pediatrics 96: 730–733PubMedGoogle Scholar
  6. 6.
    Hansen TW (1997) Acute management of extreme neonatal jaundice—the potential benefits of intensified phototherapy and interruption of enterohepatic circulation. Acta Paediatr 86: 843–846PubMedCrossRefGoogle Scholar
  7. 7.
    Kaplan M, Hammerman C, Rubaltelli FF et al (2002) Hemolysis and bilirubin conjugation in association with UDP-glucuronosyltransferase 1A1 promoter polymorphism. Hepatology 35: 905–911PubMedCrossRefGoogle Scholar
  8. 8.
    Maruo Y, Nishizawa K, Sato H et al (2000) Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate-glucuronosyltransferase gene. Pediatrics 106: e59Google Scholar
  9. 9.
    Kaplan M, Hammerman C, Renbaum P et al (2000) Gibert’s syndrome and hyperbilirubinemia in ABO-incompatible neonates. Lancet 356: 652–653PubMedCrossRefGoogle Scholar
  10. 10.
    Kaplan M, Renbaum P Levi-Lahad A et al (1997) Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci 94: 12128–12132PubMedCrossRefGoogle Scholar
  11. 11.
    Berardi A, Lugli L, Ferrari F et al (2006) Kernicterus associated with hereditary spherocytosis and UGT1A1 promoter polymorphism. Biol Neonate 90: 243–246PubMedCrossRefGoogle Scholar
  12. 12.
    Rubaltelli FF, Novello A, Vilei MT, Muraca M (1994) Serum and bile bilirubin pigments in the differential diagnosis of Crigler-Najjar disease. Pediatrics 94: 553–556PubMedGoogle Scholar
  13. 13.
    Rubaltelli FF, Guerrini P, Reddi E, Jori G (1989) Tin-protoporphyrin in the management of children with Crigler-Najjar disease. Pediatrics 84: 728–731PubMedGoogle Scholar
  14. 14.
    Rubaltelli FF, Dario C, Zancan L. (1995) Congenital nonobstructive, nonhemolytic jaundice: effect of tin-mesoporphyrin. Pediatrics 95: 942PubMedGoogle Scholar
  15. 15.
    Sarici SU, Serdar MA, Korkmaz A et al (2004) Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics 113: 775–780PubMedCrossRefGoogle Scholar
  16. 16.
    Jangaard KA, Fell DB, Dodds L, Allen AC (2008) Outcomes in a population of healthy term and near-term infants with serum bilirubin levels of 325 mol/L (19 mg/dL) who were born in Nova Scotia, Canada, between 1994 and 2000. Pediatrics 122: 119–124PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Giovanna Bertini
  • Carlo Dani
    • 1
  1. 1.Neonatal Intensive Care UnitCareggi University HospitalFlorenceItaly

Personalised recommendations